Patent: 9,415,098
✉ Email this page to a colleague
Summary for Patent: 9,415,098
Title: | DNA vaccine for use in pancreatic cancer patients |
Abstract: | The present invention relates to an attenuated mutant strain of Salmonella comprising a recombinant DNA molecule encoding a VEGF receptor protein. In particular, the present invention relate to the use of said attenuated mutant strain of Salmonella in cancer immunotherapy. |
Inventor(s): | Lubenau; Heinz (Neustadt an der Weinstrasse, DE) |
Assignee: | VAXIMM AG (Basel, CH) |
Application Number: | 14/409,434 |
Patent Claims: | see list of patent claims |
Details for Patent 9,415,098
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Emergent Travel Health, Inc. | VIVOTIF | typhoid vaccine live oral ty21a | Capsule | 103123 | 12/15/1989 | ⤷ Try a Trial | 2032-07-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |